search button

Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells

  • Authors:
    • Pengcheng Li
    • Hesong Zeng
    • Jin Qin
    • Yuanlin Zou
    • Dan  Peng
    • Houjuan Zuo
    • Zhengxiang Liu

  • View Affiliations

  • Published online on: October 27, 2014     https://doi.org/10.3892/mmr.2014.2774
  • Pages: 1258-1265
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tetraspanin protein CD151 is overexpressed in a wide variety of cancer types, including lung cancer, and is closely associated with metastasis and poor prognosis of carcinoma. To investigate whether knockdown of CD151 expression can inhibit the malignant biological behavior of lung adenocarcinoma (LAC), RNA interference technology (RNAi) was used to silence CD151 expression in the A549 LAC cell line. Specific small interfering RNA (siRNA) for targeting human endogenous CD151 were delivered into A549 cells in order to examine the effects on cell proliferation, survival, migration, invasion and colony formation. The expression levels of CD151 were assayed by western blotting, proliferation was evaluated by MTT method and apoptosis was determined by flow cytometry. The invasive and metastatic ability of A549 cells was investigated by wound healing and Boyden chamber assays. Colony formation analysis was used to determine the A549 cell growth properties. Finally, the expression of phosphorylated FAK, PI3K‑AKT, MEK‑Erk1/2, MMPs, and VEGF was detected by western blotting. The results demonstrated that CD151‑siRNA significantly decreased the expression level of CD151 in A549 cells. Reduced CD151 expression in A549 cells lead to the inhibition of cellular proliferation, migration, invasion and colony formation and an enhancement of apoptosis. Furthermore, the expression of tumor development‑related proteins, including FAK, PI3K‑AKT, MEK‑ERK1/2MAPK as well as the expression of MMP9 and VEGF, were restrained. Taken together, the present study has shown that CD151 expression is essential for LAC progression. Thus, knockdown CD151 expression by targeted siRNA could inhibit the related downstream intercellular signaling pathways, and this may provide a novel gene therapy for patients with LAC.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 11 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 6.9
  • CiteScore Rank: Q2: #98/328 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.721
  • SCImago Journal Rank (SJR): 0.65
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li P, Zeng H, Qin J, Zou Y, Peng D, Zuo H and Liu Z: Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Mol Med Rep 11: 1258-1265, 2015
APA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., & Liu, Z. (2015). Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Molecular Medicine Reports, 11, 1258-1265. https://doi.org/10.3892/mmr.2014.2774
MLA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11.2 (2015): 1258-1265.
Chicago
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11, no. 2 (2015): 1258-1265. https://doi.org/10.3892/mmr.2014.2774